My Account
Jim Weatherall, Head of Data Science and AI at AstraZeneca talks to Citi’s Adam Spielman about how AI will impact Biopharma, and how big pharma companies and small biotechs alike need to adapt.
Jim Weatherall, Head of Data Science and AI at AstraZeneca talks to Citi’s Adam Spielman about how AI will impact Biopharma, and how big pharma companies and small biotechs alike need to adapt.